SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 354,624.48 |
| Enterprise Value ($M) | 416,474.48 |
| Book Value ($M) | 6,071.00 |
| Book Value / Share | 3.44 |
| Price / Book | 58.41 |
| NCAV ($M) | -106,215.00 |
| NCAV / Share | -60.17 |
| Price / NCAV | -3.34 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.06 |
| Return on Assets (ROA) | 0.03 |
| Return on Equity (ROE) | 0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.55 |
| Current Ratio | 0.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25,582.00 |
| Assets | 135,161.00 |
| Liabilities | 131,797.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 56,334.00 |
| Operating Income | 18,317.00 |
| Net Income | 4,278.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 18,806.00 |
| Cash from Investing | -20,820.00 |
| Cash from Financing | -5,211.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.08 | 1.30 | |
| 13G/A | BlackRock, Inc. | 8.10 | 3.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 981,309 | 3,800,339 | 25.82 | |
| 939,580 | 3,759,576 | 24.99 | |
| 842,784 | 2,947,803 | 28.59 | |
| 970,509 | 4,493,109 | 21.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABT – Abbott Laboratories | ADCT – ADC Therapeutics SA |